Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy - Summary - MDSpire
Advertisement
Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy
To compare the detection rate of prostate cancer (PCa) and clinically significant prostate cancer (csPCa) using biparametric MRI (bpMRI) versus multiparametric MRI (mpMRI) in biopsy-naïve men with elevated prostate-specific antigen (PSA), emphasizing the clinical significance of this comparison.
Key Findings:
Both mpMRI and bpMRI showed substantial agreement in reader performance for PI-RADS scoring, indicating reliability in both methods.
No significant differences in cancer detection rates between bpMRI and mpMRI were observed, suggesting bpMRI may be a viable alternative.
DCE MRI's role in enhancing diagnostic accuracy remains controversial, highlighting the need for further investigation.
Interpretation:
The study suggests that bpMRI may provide comparable results to mpMRI for the detection and localization of prostate cancer, potentially reducing costs and risks associated with contrast agents, which could influence clinical practice.
Limitations:
Retrospective design may introduce selection bias, limiting the generalizability of the findings.
Limited to biopsy-naïve men, findings may not generalize to all patient populations, particularly those with prior biopsies.
Conclusion:
Biparametric MRI may serve as an effective alternative to multiparametric MRI in the detection of prostate cancer, warranting further investigation into its routine use in clinical practice to validate these findings.
by Wolfgang M. Thaiss, Simone Moser, Tobias Hepp, Stephan Kruck, Steffen Rausch, Marcus Scharpf, Konstantin Nikolaou, Arnulf Stenzl, Jens Bedke, Sascha Kaufmann
